Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.

Hong Kong medical journal = Xianggang yi xue za zhi - 1 Jun 2018

Kwong A, Shin V Y, Ma E Sk, Chan C Tl, Ford J M, Kurian A W, Tai E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Founder Effect

Share to Hong Kong

Share to Ovarian Neoplasms

Share to United States

Source

Identifiers

PMID: 29937436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.PMID 29937436Read ↗

BRCA screening.Semantic proximity Read ↗

Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing.Semantic proximity Read ↗

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.Semantic proximity Read ↗

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.Semantic proximity Read ↗

Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.Semantic proximity Read ↗

Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.Semantic proximity Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese populationSemantic proximity Read ↗

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis.Semantic proximity Read ↗

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?Semantic proximity Read ↗

Identification of Recurrent Variants in BRCA1 and BRCA2 across Multiple Cancers in the Chinese Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.